Anterix (ATEX) Revenue (2013 - 2025)

Anterix has reported Revenue for 13 years, with the latest figure at $1.6 million in Q4 2025.

• For the quarter ending Q4 2025, Revenue changed 0.45% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $5.9 million (up 0.51% YoY), and the FY2025 full-year result was $6.0 million, up 43.9% from the prior year.
• Revenue for Q4 2025 stood at $1.6 million, up from $1.6 million in the prior quarter.
• The five-year high for Revenue was $1.6 million in Q4 2025, with the low at $181000.0 in Q1 2021.
• Historically, Revenue has averaged $897450.0 across 5 years, with a median of $830000.0 in 2023.
• Annual changes were most pronounced in 2021 — Revenue plunged 44.65% — and 2023, when it jumped 164.32%.
• Anterix's Revenue stood at $385000.0 in 2021, then soared by 50.13% to $578000.0 in 2022, then soared by 119.9% to $1.3 million in 2023, then rose by 23.21% to $1.6 million in 2024, then advanced by 0.45% to $1.6 million in 2025.
• The last three Revenue figures came in at $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.